Subscribe To
Merck (mrk) keytruda studies in difficult-to-treat cancers fail
Merck (MRK) and Eisai announce the discontinuation of the phase iiI LEAP-003 study seeking approval of ...
April 10, 2023, 9:54 am
Pck: pay attention to duration, tech and the debt ceiling
PIMCO California Municipal Income Fund ii has high duration, which works on a rate pivot, but it's quit...
April 10, 2023, 9:21 am
A modern fairy tale starring king charles iii
Disney World's future hangs in the balance as the iconic theme park becomes the center of a high-stakes political battle between Florida's governor, D...
April 8, 2023, 11:30 am
Disney, desantis, and king charles iii
What do Florida's governor, Disney and the King of England have in common? David Westin takes a look in this week's One More Thought....
April 7, 2023, 4:17 pm
Aadi bioscience to present multiple posters at the american association for cancer research (aacr) annual meeting 2023
LOS ANGELES , April 6, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing a...
April 6, 2023, 4:35 pm
Immunic's (imux) ulcerative colitis study shows positive data
Immunic (IMUX) reports positive results from the maintenance phase of the phase ii study evaluating its...
April 6, 2023, 3:14 pm
Interrent reit announces timing of first quarter 2023 results and conference call
OTTAWA, Ontario--(BUSINESS WIRE)--InterRent Real Estate Investment Trust (TSX-iiP.UN) (“InterRent”)...
April 6, 2023, 3:00 pm
Isg to announce first-quarter financial results
STAMFORD, Conn.--(BUSINESS WIRE)---- $iiI #earnings--Information Services Group (ISG) (Nasdaq: ...
April 6, 2023, 11:00 am
Astrazeneca premium justified by long-term potential says broker
Encouraging Phase iiI DUO-O trial results from a new combination of AstraZeneca's Imfinzi and Lynparza ...
April 6, 2023, 7:20 am
Blackstone holdings iii now owns 60.3% of finance of america companies
Fintel reports that Blackstone Holdings iiI has filed a 13D/A form with the SEC disclosing ownership of...
April 5, 2023, 10:23 pm
Oceaneering international (oii) flat as market sinks: what you should know
Oceaneering International (Oii) closed at $17.45 in the latest trading session, marking no change from ...
April 5, 2023, 7:47 pm
Cardiovascular systems (csii) finishes eclipse trial enrollment
Cardiovascular Systems' (CSii) ECLIPSE clinical trial data is likely to help physicians form an optimal...
April 5, 2023, 10:40 am
Kodiak copper inks agreement for ‘bought deal' private placement to raise aggregate gross proceeds of approximately $5m
Kodiak Copper Corp. (TSX-V:KDK) said it has entered into an agreement with Cormark Securities Inc, as lead underwriter, in connection with a ‘bought...
April 5, 2023, 6:39 am
Astrazeneca drug combo improves ovarian cancer survival rate
AstraZeneca PLC (LSE:AZN), the Anglo-Swedish pharmaceutical giant, has announced encouraging results from a planned interim analysis of its DUO-O phas...
April 5, 2023, 3:07 am
Odyssey semiconductor to present at emerging growth conference on april 5, 2023
Live, Interactive Presentation and Questions & Answers Webcast ITHACA, NY / ACCESSWIRE / April 4, 2023 / Odyssey Semiconductor Technologies, Inc. (OTC...
April 4, 2023, 4:10 pm
Why snowflake stock is gaining in a down day for the market
Striim announced today that it will bring data-streaming features to Snowflake's Data Cloud. The new da...
April 4, 2023, 3:32 pm
Innovative industrial properties (iipr) flat as market gains: what you should know
Innovative Industrial Properties (iiPR) closed at $75.99 in the latest trading session, marking no chan...
April 3, 2023, 7:46 pm
The current upswing started in october 2022: updated as of march 31, 2023
I discuss two of James Picerno's posts (Part I & Part ii) from last week. I conclude that a market uptr...
April 3, 2023, 4:19 pm
Huntington ingalls (hii) wins $1.3b deal for lpd 32 warship
Huntington Ingalls (Hii) is set to procure the detail design and construction of the LPD 32....
April 3, 2023, 12:55 pm
Respirerx pharmaceuticals highlights analogs of its anti-seizure treatment in scientific publications
RespireRx Pharmaceuticals (OTC:RSPI) Inc has announced the publication of four articles describing the pharmacological activity of novel structural an...
April 3, 2023, 10:06 am